January 29th 2025, 9:37pm
A panelist discusses how caregivers can support patients with polycythemia vera (PV) by helping track symptoms, managing medical appointments and recognizing warning signs that require physician intervention.
January 29th 2025, 4:00pm
Dr. Anna Arthur discusses the NOURISH trial, which aims to address food insecurity and malnutrition in patients with blood cancers undergoing treatment.
January 28th 2025, 2:00pm
Dr. Ritu Salani shared her advice for patients undergoing advanced treatment options for their cervical cancer who are experiencing side effects.
January 26th 2025, 3:00pm
Dr. Scott Kopetz discusses the BREAKWATER trial investigating Braftovi and Erbitux plus chemo in those with BRAF V600E+ metastatic colorectal cancer.
January 25th 2025, 7:36pm
Dr. Susumu Hijioka spoke about the benefit of this combination therapy in patients with unresectable or recurrent GEP-NETs, particularly those with high Ki-67 scores.
January 22nd 2025, 9:37pm
A panelist discusses how patients should communicate comprehensively with their care team about symptom patterns, documentation methods, and warning signs of polycythemia vera progression, including key questions to ask themselves about symptom changes and recommended tracking tools.
January 22nd 2025, 3:00pm
Dr. David A Braun delved into detail on the molecular factors driving exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.
January 22nd 2025, 2:00pm
Yescarta continued to demonstrate durable responses after a median follow-up of more than five years in patients with R/R indolent non-Hodgkin lymphoma.
January 21st 2025, 4:00pm
An expert spoke with CURE about providers’ “two-fold goal” when using chemotherapy to treat patients with breast cancer.
January 20th 2025, 8:00pm
An expert spoke with CURE® about the emotional bonds that can develop while treating patients with cancer.
A Cancer Survivor Rethinks Cancer Ghosting
A Story of Staying Active After a Lung Cancer Diagnosis
Experts Discuss New Advances in Bladder Cancer Following ESMO 2025
What I Learned About Previvorship and Representation in Social Media